Search Results for "Drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug. Results 2261 to 2270 of 2586 total matches.

In Brief: Oral Minoxidil for Hair Loss

   
The Medical Letter on Drugs and Therapeutics • Dec 26, 2022  (Issue 1666)
with an oral antiandrogenic drug such as spironolactone.1 Oral minoxidil, which is available by prescription ...
Topical minoxidil (Rogaine, and others), which is available over the counter, has been used for treatment of hair loss in men and women for more than 30 years. Recently published trials suggest that off-label use of a low dose of oral minoxidil may also be effective.
Med Lett Drugs Ther. 2022 Dec 26;64(1666):208 |  Show IntroductionHide Introduction

Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 17, 2025  (Issue 1722)
Drug/Formulations Class Approved Age Efficacy at 16 Weeks1 Usual Adult Dosage Cost2 Dupilumab ...
View the Comparison Chart: Interleukin (IL) Receptor Antagonists for Atopic Dermatitis
Med Lett Drugs Ther. 2025 Feb 17;67(1722):e1   doi:10.58347/tml.2025.1722f |  Show IntroductionHide Introduction

High Altitude Sickness

   
The Medical Letter on Drugs and Therapeutics • Sep 04, 1992  (Issue 878)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Rapid exposure to altitudes more than 8,000 feet above sea level can cause serious medical problems. Since the last Medical Letter article on this subject (Vol. 30, page 89, 1988), some new information on prevention and treatment of these disorders has been reported.
Med Lett Drugs Ther. 1992 Sep 4;34(878):84-6 |  Show IntroductionHide Introduction

Radiofrequency Catheter Ablation for Treatment of Cardiac Arrhythmias

   
The Medical Letter on Drugs and Therapeutics • Apr 26, 1996  (Issue 973)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
In recent years, selective destruction of cardiac tissue by radiofrequency energy has become a routine procedure for treatment of some types of cardiac arrhythmias, particularly supraventricular tachycardias (MM Scheinman, Pacing Clin Electrophysiol, 18:1474, 1995).
Med Lett Drugs Ther. 1996 Apr 26;38(973):40-2 |  Show IntroductionHide Introduction

Insulin Glargine (Lantus), A New Long-acting Insulin

   
The Medical Letter on Drugs and Therapeutics • Aug 06, 2001  (Issue 1110)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Insulin Glargine (Lantus) is a new long-acting human insulin analog approved by the FDA for treatment of both type 1 and type 2 diabetes. Synthesized by recombinant DNA technology, it differs from human insulin at position 21 in the A-chain where asparagine is replaced by glycine and at the C-terminus of the B-chain where two arginines are added.
Med Lett Drugs Ther. 2001 Aug 6;43(1110):65-6 |  Show IntroductionHide Introduction

Twinrix: A Combination Hepatitis A and B Vaccine

   
The Medical Letter on Drugs and Therapeutics • Aug 06, 2001  (Issue 1110)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
A vaccine to prevent both Hepatitis A and Hepatitis B (Twinrix), previously licensed in Canada and Europe, is now available in the US for adults.
Med Lett Drugs Ther. 2001 Aug 6;43(1110):67-8 |  Show IntroductionHide Introduction

Darbepoetin (Aranesp) - A long-acting Erythropoietin

   
The Medical Letter on Drugs and Therapeutics • Dec 10, 2001  (Issue 1120)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Darbepoetin alfa (Aranesp) has been approved by the FDA for treatment of anemia caused by chronic renal disease and will probably also be approved for use in patients with cancer..
Med Lett Drugs Ther. 2001 Dec 10;43(1120):109-10 |  Show IntroductionHide Introduction

Antiviral KLEENEX

   
The Medical Letter on Drugs and Therapeutics • Jan 03, 2005  (Issue 1199)
The Medical Letter ® On Drugs and Therapeutics 3 FORWARDING OR COPYING IS A VIOLATION OF U.S ...
The first commercially available virucidal tissue, KLEENEX Anti-Viral Tissue (Kimberly-Clark), was recently introduced and is being heavily promoted to the general public. Patients may ask healthcare providers about the usefulness of these products. Theoretically, virucidal tissues could interrupt transmission of viral infections by blocking hand contamination and/or small particle aerosols from nose-blowing, sneezing and coughing.
Med Lett Drugs Ther. 2005 Jan 3;47(1199):3-4 |  Show IntroductionHide Introduction

Virtual Colonoscopy

   
The Medical Letter on Drugs and Therapeutics • Feb 14, 2005  (Issue 1202)
Letter ® On Drugs and Therapeutics IN THIS ISSUE Volume 47 (Issue 1202) February 14, 2005 ...
Currently available techniques for colorectal cancer screening include fecal occult-blood testing, flexible sigmoidoscopy, double contrast barium enema (DCBE) and traditional optical colonoscopy. Optical colonoscopy requires bowel cleansing and sedation, and involves some risk, but is generally accepted as the best available method for detection of lesions and offers the advantage that polyps can be removed when they are identified. A less invasive screening tool, computed tomography (CT) colonography, also known as virtual colonoscopy (VC), offers an additional option.
Med Lett Drugs Ther. 2005 Feb 14;47(1202):15-6 |  Show IntroductionHide Introduction

Ceftaroline Fosamil (Teflaro) - A New IV Cephalosporin

   
The Medical Letter on Drugs and Therapeutics • Jan 24, 2011  (Issue 1356)
The Medical Letter® On Drugs and Therapeutics Volume 53 (Issues 1356) January 24, 2011 ...
The FDA has approved ceftaroline fosamil (Teflaro – Forest), an intravenous (IV) cephalosporin, for treatment of acute bacterial skin and skin structure infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA), and for treatment of community-acquired bacterial pneumonia in adults. It is the first beta-lactam antibiotic approved for treatment of MRSA.
Med Lett Drugs Ther. 2011 Jan 24;53(1356):5-6 |  Show IntroductionHide Introduction